Talphera Inc (TLPH) Stock Price, Quote & News

Company Profile

Talphera, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for use in medically supervised settings. The company's lead product candidate, Niyad, is a lyophilized formulation of nafamostat that acts as a regional anticoagulant for infusion into the extracorporeal circuit. It is also developing LTX-608, a lyophilized vial containing nafamostat for IV infusion for disseminated intravascular coagulation, acute respiratory distress syndrome, acu...

Industry: Drug Manufacturers - Specialty & Generic

Sector: Healthcare

Phone: 650 216 3500

Website: talphera.com

Address:

1850 Gateway Drive, Suite 175, San Mateo, United States

CaliEmpress Jul. 3 at 4:24 PM

$CRMD We now know they are gearing up for a merger, acquisition or buyout. The question remains is it $TLPH or Big Pharma?

2 · Reply

Stonehands Jul. 2 at 8:30 PM

$TLPH

0 · Reply

Stonehands Jul. 2 at 8:01 PM

$TLPH Train kept a rollin

0 · Reply

Stonehands Jul. 1 at 8:51 PM

$TLPH

1 · Reply

barlaw Jul. 1 at 6:20 PM

$TLPH C’mon now! Be ready to have those At-The-Close limit buy orders in ahead of time enough at $1.01, or $1.005, or whatever. Only 4 days left of closing AT or ABOVE $1 to keep the NASDAQ regulators happy. I think retail can actually have a say here.

1 · Reply

Crandaddy01 Jul. 1 at 2:22 PM

$TLPH

0 · Reply

Estimize Jul. 1 at 1:06 PM

Wall St is expecting -0.06 EPS for $TLPH Q2 [Reporting 08/19 AMC] http://www.estimize.com/intro/tlph?chart=historical&metric_name=eps&utm_c

0 · Reply

Stonehands Jun. 30 at 10:44 PM

$TLPH

0 · Reply

SweStonk Jun. 30 at 3:28 PM

$CRMD $TLPH nah, CRMD is following market perfect dont know what you are looking at. Two of your losers ? 😂 So many bots.....

0 · Reply

firedupinvestors Jun. 30 at 2:42 PM

$CRMD $TLPH market roaring but these 2 stuck in da mud.

0 · Reply

Talphera Transcript: AGM 2026

2026-06-05T10:27:07.000Z - 4 weeks ago

Talphera assumed with a Buy at H.C. Wainwright

2026-05-13T21:03:38.000Z - 7 weeks ago

Talphera reports Q1 EPS (4c) vs. (10c) last year

May 13, 2026, 4:30 PM EDT - 7 weeks ago

Talphera Earnings Call Transcript: Q1 2026

May 13, 2026, 4:30 PM EDT - 7 weeks ago

Talphera Earnings release: Q1 2026

May 13, 2026, 4:30 PM EDT - 7 weeks ago

Talphera Quarterly report: Q1 2026

May 13, 2026, 4:05 PM EDT - 7 weeks ago

Talphera Announces First Quarter 2026 Financial Results and Provides Corporate Update

May 7, 2026, 4:05 PM EDT - 2 months ago

Talphera to Host First Quarter Financial Results and Corporate Update Call and Webcast on Wednesday, May 13, 2026

2026-04-30T18:25:47.000Z - 2 months ago

Talphera initiated with a Buy at WestPark Capital

Apr 29, 2026, 8:00 AM EDT - 2 months ago

Talphera Proxy statement: Proxy filing

Apr 29, 2026, 8:00 AM EDT - 2 months ago

Talphera Proxy statement: Proxy filing

Apr 9, 2026, 7:00 AM EDT - 3 months ago

Talphera Slides: Corporate presentation

Mar 25, 2026, 8:30 AM EDT - 3 months ago

Talphera Announces Two Abstracts Accepted for Presentation at AKI & CRRT 2026

Mar 25, 2026, 8:00 AM EDT - 3 months ago

Talphera Registration statement: Registration filing

2026-03-25T10:05:29.000Z - 3 months ago

Talphera files to sell 639,931 shares of common stock for holders

Mar 23, 2026, 11:00 AM EDT - 3 months ago

Talphera Earnings Call Transcript: Q4 2025

Mar 23, 2026, 11:00 AM EDT - 3 months ago

Talphera Annual report: Q4 2025

Mar 23, 2026, 11:00 AM EDT - 3 months ago

Talphera Earnings release: Q4 2025

2026-03-23T12:41:43.000Z - 3 months ago

Talphera reports Q4 EPS (6c) vs. (7c) last year

Mar 23, 2026, 8:30 AM EDT - 3 months ago

Talphera Announces Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update

Mar 18, 2026, 4:05 PM EDT - 3 months ago

Talphera to Host Virtual Investor & Analyst Event to Discuss Niyad® for Use in Continuous Renal Replacement Therapy (CRRT), on March 23, 2026

2026-03-02T13:48:08.000Z - 4 months ago

Talphera announces 50% patient enrollment of the NEPHRO-CRRT clinical trial

Mar 2, 2026, 8:30 AM EST - 4 months ago

Talphera Announces 50% Enrollment Milestone in Ongoing NEPHRO-CRRT Registrational Trial

Nov 12, 2025, 4:30 PM EST - 8 months ago

Talphera Earnings Call Transcript: Q3 2025

Nov 12, 2025, 4:30 PM EST - 8 months ago

Talphera Quarterly report: Q3 2025

Nov 12, 2025, 4:30 PM EST - 8 months ago

Talphera Earnings release: Q3 2025

2025-11-12T21:23:13.000Z - 8 months ago

Talphera reports Q3 EPS (11c) vs. (13c) last year

Nov 12, 2025, 4:05 PM EST - 8 months ago

Talphera Announces Third Quarter 2025 Financial Results and Provides Corporate Update

CRMD

Nov 5, 2025, 4:05 PM EST - 8 months ago

Talphera to Host Third Quarter Financial Results and Corporate Update Call and Webcast on Wednesday, November 12, 2025

2025-10-28T20:36:26.000Z - 8 months ago

Talphera files to sell 1.02M shares of common stock for holders

Oct 28, 2025, 8:00 AM EDT - 8 months ago

Talphera Registration statement: Registration Filing

Oct 21, 2025, 8:30 AM EDT - 9 months ago

Talphera Announces the Appointment of Joe Todisco to Board of Directors

2025-09-22T21:15:15.000Z - 10 months ago

Talphera files to sell 25.04M shares of common stock for holders

Sep 22, 2025, 8:00 AM EDT - 10 months ago

Talphera Registration statement: Registration Filing

Sep 9, 2025, 8:00 AM EDT - 10 months ago

Talphera Proxy statement: Proxy Filing

Sep 9, 2025, 8:00 AM EDT - 10 months ago

Talphera Proxy statement: Proxy Filing

2025-09-08T12:45:47.000Z - 10 months ago

CorMedix makes $5M minority equity investment in Talphera

CRMD

Sep 8, 2025, 8:30 AM EDT - 10 months ago

CorMedix Announces Strategic Minority Investment in Talphera

CRMD

Sep 8, 2025, 8:30 AM EDT - 10 months ago

Talphera Announces Private Placement Financing of up to $29 Million Priced At-the Market

CRMD

Aug 29, 2025, 8:00 AM EDT - 11 months ago

Talphera Proxy statement: Proxy Filing

2025-08-25T12:35:24.000Z - 11 months ago

Talphera enrolls 17 patients in 70-patient pivotal NEPHRO CRRT clinical trial

Aug 25, 2025, 8:30 AM EDT - 11 months ago

Talphera Announces Achievement of 17 Patient Enrollment Milestone in NEPHRO CRRT Pivotal Trial

Aug 14, 2025, 4:30 PM EDT - 11 months ago

Talphera Earnings Call Transcript: Q2 2025

Aug 14, 2025, 4:30 PM EDT - 11 months ago

Talphera Quarterly report: Q2 2025

Aug 14, 2025, 4:30 PM EDT - 11 months ago

Talphera Earnings release: Q2 2025

2025-08-14T20:16:22.000Z - 11 months ago

Talphera reports Q2 EPS (10c) vs. (15c) last year

2025-08-14T20:16:01.000Z - 11 months ago

Talphera lowers 2025 cash operating expense view to $16M-$17M from $17M-$19M

Aug 14, 2025, 4:05 PM EDT - 11 months ago

Talphera Announces Second Quarter 2025 Financial Results and Provides Corporate Update

Aug 7, 2025, 4:35 PM EDT - 11 months ago

Talphera to Host Second Quarter Financial Results and Corporate Update Call and Webcast on Thursday, August 14, 2025

May 14, 2025, 4:30 PM EDT - 1 year ago

Talphera Earnings Call Transcript: Q1 2025

May 14, 2025, 4:30 PM EDT - 1 year ago

Talphera Quarterly report: Q1 2025

May 14, 2025, 4:30 PM EDT - 1 year ago

Talphera Earnings release: Q1 2025

2025-05-14T20:17:58.000Z - 1 year ago

Talphera reports Q1 EPS (10c), consensus (14c)

2025-05-14T20:17:33.000Z - 1 year ago

Talphera sees 2025 expenses $17M-$19M

May 14, 2025, 4:05 PM EDT - 1 year ago

Talphera Announces First Quarter 2025 Financial Results and Provides Corporate Update

May 7, 2025, 4:05 PM EDT - 1 year ago

Talphera to Host First Quarter Financial Results and Corporate Update Call and Webcast on Wednesday, May 14, 2025

2025-05-02T21:20:14.000Z - 1 year ago

Talphera files to sell 3.41M shares of common stock for holders

May 2, 2025, 8:00 AM EDT - 1 year ago

Talphera Registration statement: Registration Filing

Mar 31, 2025, 4:30 PM EDT - 1 year ago

Talphera Earnings Call Transcript: Q4 2024

Mar 31, 2025, 4:30 PM EDT - 1 year ago

Talphera Annual report: Q4 2024

Mar 31, 2025, 4:30 PM EDT - 1 year ago

Talphera Earnings release: Q4 2024

2025-03-31T20:11:33.000Z - 1 year ago

Talphera reports Q4 EPS (7c) vs. (25c) last year

Mar 31, 2025, 4:05 PM EDT - 1 year ago

Talphera Announces Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update

2025-03-31T12:40:30.000Z - 1 year ago

Talphera announces agreement with FDA to reduce NEPHRO CRRT study size

Mar 31, 2025, 8:30 AM EDT - 1 year ago

Talphera Announces Agreement with the FDA to Reduce the NEPHRO CRRT Study Size to 70 Patients From 166 and a Private Placement Financing Priced At-the Market of up to $14.8 Million

Mar 26, 2025, 4:38 PM EDT - 1 year ago

Talphera to Host Fourth Quarter and Full-Year 2024 Financial Results and Corporate Update Call and Webcast on Monday, March 31, 2025

Jan 14, 2025, 8:30 AM EST - 1 year ago

Talphera Announces Agreement with the FDA for Prior Approval Supplement Review to Reduce the Number of Patients in the NEPHRO CRRT Study

Nov 13, 2024, 4:30 PM EST - 1 year ago

Talphera Earnings Call Transcript: Q3 2024

Nov 13, 2024, 4:30 PM EST - 1 year ago

Talphera Quarterly report: Q3 2024

Nov 13, 2024, 4:30 PM EST - 1 year ago

Talphera Earnings release: Q3 2024

Nov 13, 2024, 4:05 PM EST - 1 year ago

Talphera Announces Third Quarter 2024 Financial Results and Provides Corporate Update

Nov 6, 2024, 4:05 PM EST - 1 year ago

Talphera to Host Third Quarter 2024 Financial Results and Corporate Update Call and Webcast on Wednesday, November 13, 2024

Oct 16, 2024, 3:00 PM EDT - 1 year ago

Talphera Transcript: Maxim Group’s 2024 Healthcare Virtual Summit

Oct 8, 2024, 4:54 PM EDT - 1 year ago

Talphera to Participate in Fireside Chat at the 2024 Maxim Healthcare Virtual Summit

Sep 5, 2024, 4:15 PM EDT - 1 year ago

Talphera to Participate in the H.C. Wainwright 26th Annual Global Investment Conference

Aug 19, 2024, 8:30 AM EDT - 2 years ago

Talphera Announces First Patient Enrolled in the Registrational Trial Evaluating Nafamostat for Anticoagulation of the Extracorporeal Circuit

Aug 14, 2024, 4:30 PM EDT - 2 years ago

Talphera Earnings Call Transcript: Q2 2024

Aug 14, 2024, 4:30 PM EDT - 2 years ago

Talphera Quarterly report: Q2 2024

Aug 14, 2024, 4:30 PM EDT - 2 years ago

Talphera Earnings release: Q2 2024

Aug 14, 2024, 4:01 PM EDT - 2 years ago

Talphera Announces Second Quarter 2024 Financial Results and Provides Corporate Update

Aug 5, 2024, 4:05 PM EDT - 2 years ago

Talphera to Host Second Quarter 2024 Financial Results and Corporate Update Call and Webcast on Wednesday, August 14, 2024

May 20, 2024, 5:25 PM EDT - 2 years ago

Talphera Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

May 16, 2024, 5:45 PM EDT - 2 years ago

Talphera to Participate at A.G.P. Virtual Healthcare Conference

May 14, 2024, 4:30 PM EDT - 2 years ago

Talphera Earnings Call Transcript: Q1 2024

May 14, 2024, 4:30 PM EDT - 2 years ago

Talphera Quarterly report: Q1 2024

May 14, 2024, 4:30 PM EDT - 2 years ago

Talphera Earnings release: Q1 2024

May 14, 2024, 4:05 PM EDT - 2 years ago

Talphera Announces First Quarter 2024 Financial Results and Provides Corporate Update

May 2, 2024, 4:15 PM EDT - 2 years ago

Talphera to Host First Quarter 2024 Financial Results Call and Webcast on Tuesday, May 14, 2024

Apr 29, 2024, 8:00 AM EDT - 2 years ago

Talphera Proxy statement: Proxy Filing

Apr 29, 2024, 8:00 AM EDT - 2 years ago

Talphera Proxy statement: Proxy Filing

Mar 6, 2024, 4:30 PM EST - 2 years ago

Talphera Earnings Call Transcript: Q4 2023

Mar 6, 2024, 4:30 PM EST - 2 years ago

Talphera Annual report: Q4 2023

Mar 6, 2024, 4:30 PM EST - 2 years ago

Talphera Earnings release: Q4 2023

Mar 6, 2024, 4:05 PM EST - 2 years ago

Talphera Announces Fourth Quarter 2023 Financial Results and Provides Corporate Update

Mar 1, 2024, 7:30 AM EST - 2 years ago

Talphera Announces Reduction in Size of its Board of Directors from Ten to Seven Members

Feb 26, 2024, 4:15 PM EST - 2 years ago

Talphera to Host Fourth Quarter and Full-Year 2023 Financial Results Call and Webcast on March 6, 2024

Feb 6, 2024, 7:00 AM EST - 2 years ago

Talphera Registration statement: Registration Filing

Jan 18, 2024, 8:30 AM EST - 2 years ago

Talphera Announces $26 Million Capital Commitment Through a Combination of a Non-Dilutive Royalty Monetization and Equity Offering

CaliEmpress Jul. 3 at 4:24 PM

$CRMD We now know they are gearing up for a merger, acquisition or buyout. The question remains is it $TLPH or Big Pharma?

2 · Reply

Stonehands Jul. 2 at 8:30 PM

$TLPH

0 · Reply

Stonehands Jul. 2 at 8:01 PM

$TLPH Train kept a rollin

0 · Reply

Stonehands Jul. 1 at 8:51 PM

$TLPH

1 · Reply

barlaw Jul. 1 at 6:20 PM

1 · Reply

Crandaddy01 Jul. 1 at 2:22 PM

$TLPH

0 · Reply

Estimize Jul. 1 at 1:06 PM

Wall St is expecting -0.06 EPS for $TLPH Q2 [Reporting 08/19 AMC] http://www.estimize.com/intro/tlph?chart=historical&metric_name=eps&utm_c

0 · Reply

Stonehands Jun. 30 at 10:44 PM

$TLPH

0 · Reply

SweStonk Jun. 30 at 3:28 PM

$CRMD $TLPH nah, CRMD is following market perfect dont know what you are looking at. Two of your losers ? 😂 So many bots.....

0 · Reply

firedupinvestors Jun. 30 at 2:42 PM

$CRMD $TLPH market roaring but these 2 stuck in da mud.

0 · Reply

Brunoez Jun. 29 at 11:32 PM

$TLPH 5 trading days above $1.00 now, 5 more to go. Study completion news will be released somewhere between July and October. I'll stay optimistic and say July. Any pessimists here??

0 · Reply

barlaw Jun. 26 at 9:42 PM

$TLPH 4 days and counting!

0 · Reply

Hendwey Jun. 26 at 6:43 PM

$TLPH Really that hard to stay above a dollar huh?🤔🙄

0 · Reply

Brunoez Jun. 25 at 3:02 PM

$TLPH I sold 10K shares to lighten my load a bit. If the stock skyrockets tomorrow, y'all can thank me. 😀

1 · Reply

kspar1 Jun. 25 at 2:02 AM

$TLPH I think we're enjoying the upside of a stock rotation away from data center / spcx bubble concerns. With so much i this stock, I'm good with backing away from st;ock prices.

0 · Reply

Brunoez Jun. 24 at 5:07 PM

$TLPH I'm back to even after going $20K in the hole on this stock. I'm still dreaming of $4-$5, but will be super-excited to even reach $2 at this point.

1 · Reply

Stonehands Jun. 24 at 4:01 PM

$TLPH theres something happening here

0 · Reply

nazzangr Jun. 23 at 6:45 PM

$TLPH lets see how it closes today lol red or green~?

0 · Reply

Yoda896 Jun. 23 at 4:17 PM

$TLPH It's 100% normal. People don't know if the results are out very soon or close to the end of year. When they think it's soon, they panick buy. When they think it's not, they panick sell.

0 · Reply

nazzangr Jun. 23 at 3:49 PM

$TLPH anticipation build up!?

0 · Reply

Stonehands Jun. 23 at 3:24 PM

$TLPH ok, can we all agree this is not normal?

0 · Reply

Crandaddy01 Jun. 23 at 1:40 PM

$TLPH

0 · Reply

Market Cap	55.53M
Revenue (ttm)	30,000.00
Net Income (ttm)	-14.29M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-47,633.33%
Debt to Equity Ratio	0.00

Volume	427,100
Avg Vol	195,826
Day's Range	N/A - N/A
Shares Out	51.90M
Stochastic %K	63%
Beta	0.70
Analysts	Strong Sell
Price Target	$3.17